Annual CFO
-$132.18 M
+$45.17 M+25.47%
31 December 2023
Summary:
Editas Medicine annual cash flow from operations is currently -$132.18 million, with the most recent change of +$45.17 million (+25.47%) on 31 December 2023. During the last 3 years, it has risen by +$47.66 million (+26.50%). EDIT annual CFO is now -2328.40% below its all-time high of -$5.44 million, reached on 31 December 2015.EDIT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$52.59 M
+$4.47 M+7.84%
30 September 2024
Summary:
Editas Medicine quarterly cash flow from operations is currently -$52.59 million, with the most recent change of +$4.47 million (+7.84%) on 30 September 2024. Over the past year, it has dropped by -$17.13 million (-48.31%). EDIT quarterly CFO is now -175.35% below its all-time high of $69.79 million, reached on 31 March 2017.EDIT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$181.76 M
-$17.13 M-10.40%
30 September 2024
Summary:
Editas Medicine TTM cash flow from operations is currently -$181.76 million, with the most recent change of -$17.13 million (-10.40%) on 30 September 2024. Over the past year, it has dropped by -$29.55 million (-19.41%). EDIT TTM CFO is now -723.03% below its all-time high of $29.17 million, reached on 31 March 2017.EDIT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.5% | -48.3% | -19.4% |
| 3 y3 years | +26.5% | -28.9% | -7.3% |
| 5 y5 years | -189.2% | -95.6% | -126.2% |
EDIT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.5% | -136.5% | +7.8% | -37.5% | at low |
| 5 y | 5 years | -225.0% | +26.5% | -228.2% | +7.8% | -346.9% | +0.9% |
| alltime | all time | -2328.4% | +26.5% | -175.3% | +7.8% | -723.0% | +0.9% |
Editas Medicine Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$52.59 M(-7.8%) | -$181.76 M(+10.4%) |
| June 2024 | - | -$57.06 M(+14.4%) | -$164.63 M(+12.5%) |
| Mar 2024 | - | -$49.87 M(+124.2%) | -$146.28 M(+10.7%) |
| Dec 2023 | -$132.18 M(-25.5%) | -$22.24 M(-37.3%) | -$132.18 M(-13.2%) |
| Sept 2023 | - | -$35.46 M(-8.4%) | -$152.21 M(-7.6%) |
| June 2023 | - | -$38.71 M(+8.2%) | -$164.76 M(+0.5%) |
| Mar 2023 | - | -$35.77 M(-15.4%) | -$163.89 M(-7.6%) |
| Dec 2022 | -$177.35 M(+8.3%) | -$42.27 M(-11.9%) | -$177.35 M(+4.5%) |
| Sept 2022 | - | -$48.00 M(+26.8%) | -$169.66 M(+4.4%) |
| June 2022 | - | -$37.84 M(-23.1%) | -$162.44 M(-0.7%) |
| Mar 2022 | - | -$49.23 M(+42.3%) | -$163.55 M(-0.2%) |
| Dec 2021 | -$163.80 M(-8.9%) | -$34.58 M(-15.2%) | -$163.80 M(-3.3%) |
| Sept 2021 | - | -$40.78 M(+4.7%) | -$169.32 M(-7.6%) |
| June 2021 | - | -$38.96 M(-21.3%) | -$183.34 M(+4.6%) |
| Mar 2021 | - | -$49.48 M(+23.4%) | -$175.24 M(-2.6%) |
| Dec 2020 | -$179.84 M(+342.2%) | -$40.10 M(-26.8%) | -$179.84 M(+82.2%) |
| Sept 2020 | - | -$54.80 M(+77.6%) | -$98.72 M(+39.4%) |
| June 2020 | - | -$30.86 M(-43.0%) | -$70.80 M(+7.7%) |
| Mar 2020 | - | -$54.09 M(-231.8%) | -$65.75 M(+61.7%) |
| Dec 2019 | -$40.67 M | $41.02 M(-252.6%) | -$40.67 M(-49.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$26.88 M(+4.2%) | -$80.37 M(+31.1%) |
| June 2019 | - | -$25.81 M(-11.0%) | -$61.32 M(+17.4%) |
| Mar 2019 | - | -$29.00 M(-2285.6%) | -$52.25 M(+14.3%) |
| Dec 2018 | -$45.71 M(+385.4%) | $1.33 M(-116.9%) | -$45.71 M(-36.6%) |
| Sept 2018 | - | -$7.84 M(-53.1%) | -$72.10 M(-21.8%) |
| June 2018 | - | -$16.73 M(-25.5%) | -$92.24 M(-9.3%) |
| Mar 2018 | - | -$22.46 M(-10.4%) | -$101.67 M(+979.6%) |
| Dec 2017 | -$9.42 M(-81.3%) | -$25.07 M(-10.4%) | -$9.42 M(-576.8%) |
| Sept 2017 | - | -$27.98 M(+6.9%) | $1.98 M(-84.7%) |
| June 2017 | - | -$26.16 M(-137.5%) | $12.91 M(-55.7%) |
| Mar 2017 | - | $69.79 M(-610.3%) | $29.17 M(-158.1%) |
| Dec 2016 | -$50.25 M(+823.1%) | -$13.68 M(-19.7%) | -$50.25 M(+12.7%) |
| Sept 2016 | - | -$17.04 M(+72.1%) | -$44.58 M(+12.9%) |
| June 2016 | - | -$9.90 M(+2.8%) | -$39.48 M(+332.4%) |
| Mar 2016 | - | -$9.63 M(+20.2%) | -$9.13 M(+67.7%) |
| Dec 2015 | -$5.44 M(-37.1%) | -$8.01 M(-32.9%) | -$5.44 M(-312.2%) |
| Sept 2015 | - | -$11.94 M(-158.4%) | $2.56 M(-82.3%) |
| June 2015 | - | $20.45 M(-444.1%) | $14.51 M(-344.1%) |
| Mar 2015 | - | -$5.94 M | -$5.94 M |
| Dec 2014 | -$8.65 M | - | - |
FAQ
- What is Editas Medicine annual cash flow from operations?
- What is the all time high annual CFO for Editas Medicine?
- What is Editas Medicine annual CFO year-on-year change?
- What is Editas Medicine quarterly cash flow from operations?
- What is the all time high quarterly CFO for Editas Medicine?
- What is Editas Medicine quarterly CFO year-on-year change?
- What is Editas Medicine TTM cash flow from operations?
- What is the all time high TTM CFO for Editas Medicine?
- What is Editas Medicine TTM CFO year-on-year change?
What is Editas Medicine annual cash flow from operations?
The current annual CFO of EDIT is -$132.18 M
What is the all time high annual CFO for Editas Medicine?
Editas Medicine all-time high annual cash flow from operations is -$5.44 M
What is Editas Medicine annual CFO year-on-year change?
Over the past year, EDIT annual cash flow from operations has changed by +$45.17 M (+25.47%)
What is Editas Medicine quarterly cash flow from operations?
The current quarterly CFO of EDIT is -$52.59 M
What is the all time high quarterly CFO for Editas Medicine?
Editas Medicine all-time high quarterly cash flow from operations is $69.79 M
What is Editas Medicine quarterly CFO year-on-year change?
Over the past year, EDIT quarterly cash flow from operations has changed by -$17.13 M (-48.31%)
What is Editas Medicine TTM cash flow from operations?
The current TTM CFO of EDIT is -$181.76 M
What is the all time high TTM CFO for Editas Medicine?
Editas Medicine all-time high TTM cash flow from operations is $29.17 M
What is Editas Medicine TTM CFO year-on-year change?
Over the past year, EDIT TTM cash flow from operations has changed by -$29.55 M (-19.41%)